Magneto-Endosomalytic Therapy for Cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34355530.
- Also identified by DOI 10.1002/adhm.202101010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A remarkably simple yet effective mode of cancer treatment is reported by repurposing clinically approved magnetic nanoparticles (MNPs). Intracellular nanoparticle self-assembly directed by static parallel magnetic fields leads to cell death in targeted tissues while leaving other cells and organs intact. This simple concept opens a new avenue to treat cancer, capitalizing on nanosciences and the nanoparticle (NP) design principles accumulated in the past decades.
Medical subject headings
- Nanoparticles
- Neoplasms